The activity of hypoxia-inducible transcription factor HIF, an ␣␤ heterodimer that has an essential role in adaptation to low oxygen availability, is regulated by two oxygen-dependent hydroxylation events. Hydroxylation of specific proline residues by HIF prolyl 4-hydroxylases targets the HIF-␣ subunit for proteasomal destruction, whereas hydroxylation of an asparagine in the C-terminal transactivation domain prevents its interaction with the transcriptional coactivator p300. The HIF asparaginyl hydroxylase is identical to a previously known factor inhibiting HIF (FIH). We report here that recombinant FIH has unique catalytic and inhibitory properties when compared with those of the HIF prolyl 4-hydroxylases. FIH was found to require particularly long peptide substrates so that omission of only a few residues from the N or C terminus of a 35-residue HIF-1␣ sequence markedly reduced its substrate activity. Hydroxylation of two HIF-2␣ peptides was far less efficient than that of the corresponding HIF-1␣ peptides. The K m of FIH for O 2 was about 40% of its atmospheric concentration, being about one-third of those of the HIF prolyl 4-hydroxylases but 2.5 times that of the type I collagen prolyl 4-hydroxylase. Several 2-oxoglutarate analogs were found to inhibit FIH but with distinctly different potencies from the HIF prolyl 4-hydroxylases. For example, the two most potent HIF prolyl 4-hydroxylase inhibitors among the compounds studied were the least effective ones for FIH. It should therefore be possible to develop specific small molecule inhibitors for the two enzyme classes involved in the hypoxia response.
The hypoxia-inducible transcription factor HIF 1 has a major role in the conserved oxygen-sensitive response pathway that is activated in hypoxic cells. HIF-regulated hypoxia-inducible genes are involved in angiogenesis, vascularization, and anaerobic energy production, for instance. HIFs are ␣␤ heterodimers in which the stability of the ␣ subunit is regulated in an oxygen-dependent manner (for reviews, see Refs. [1] [2] [3] [4] . Hydroxylation of at least one of two proline residues, Pro 402 and Pro 564 , in the oxygen-dependent degradation domain of human HIF-1␣ mediates the interaction of HIF-␣ with the von Hippel Lindau E3 (ubiquitin-protein isopeptide ligase) ubiquitin ligase complex that targets it for rapid proteasomal degradation under normoxic conditions (5) (6) (7) (8) . This hydroxylation is catalyzed in humans by three novel cytoplasmic and nuclear HIF prolyl 4-hydroxylases (9 -11) that are distinct from the well characterized collagen prolyl 4-hydroxylases, which reside in the lumen of the endoplasmic reticulum (12) (13) (14) (15) (16) . Under hypoxic conditions, the oxygen-requiring process of hydroxylation is prevented, and HIF-␣ escapes degradation and dimerizes with HIF-␤, the dimer then recognizing a specific element in the promoters of hypoxia-responsive target genes (1) (2) (3) (4) .
Transcriptional activation in an oxygen-dependent manner is another key step that regulates HIF-␣ activity. Hydroxylation of a specific asparagine residue, Asn 803 , in the C-terminal transactivation domain of human HIF-1␣ has recently been shown to block its interaction with the transcriptional coactivator p300 (17) . The HIF asparaginyl hydroxylase responsible for this is identical to the previously identified protein termed the factor inhibiting HIF (FIH) (18, 19) . The prolyl 4-hydroxylases (9 -16) and FIH (18, 19) belong to the family of 2-oxoglutarate-dependent dioxygenases and require Fe 2ϩ , 2-oxoglutarate, O 2 , and ascorbate for their reactions. The crystal structure of FIH has recently been resolved, and thus detailed information is available on the binding of the peptide substrate and cosubstrates to the enzyme (20 -22) . However, almost no detailed data are available on the catalytic properties of FIH.
The HIF prolyl 4-hydroxylases were recently shown to be very effective oxygen sensors, as their K m values for O 2 are slightly above its atmospheric concentration (23) . Furthermore, 2-oxoglutarate analogs were shown to inhibit the HIF prolyl 4-hydroxylases but with distinctly different K i values from those of the collagen prolyl 4-hydroxylases, whereas differences were also found between the individual HIF prolyl 4-hydroxylase isoenzymes (23) . In the present study, we expressed human FIH as a recombinant protein in insect cells, examined its requirements for peptide substrates, and determined its kinetic constants for cosubstrates and several 2-oxoglutarate analog inhibitors. Our data indicate distinct differences between FIH and the three human HIF prolyl 4-hydroxylases in their K m values for O 2 and inhibition by 2-oxoglutarate analogs. the pMOSBlue blunt-ended cloning kit (Amersham Biosciences). The full-length FIH cDNA was cloned into the pVL1392, pBlueBacHis (Nterminal His tag), and pAcG3X (N-terminal GST tag) baculovirus expression vectors (Pharmingen). FLAGHis and V5His tags were amplified by PCR from the plasmids d28e6 and d28e5 (FibroGen Inc.), respectively, and cloned into the 3Ј end before the stop codon of the FIH cDNA in pVL1392.
MATERIALS AND METHODS

Generation of Insect Cell Expression Constructs for Untagged and
Expression of Recombinant FIH in Insect Cells and Purification of the Enzyme-The recombinant baculovirus expression vectors were cotransfected into Spodoptera frugiperda Sf9 cells with BaculoGold DNA (Pharmingen) by calcium phosphate transfection, and the recombinant viruses were amplified (24) . Sf9 or High Five insect cells (Invitrogen) were cultured as monolayers in TNM-FH medium (Sigma) supplemented with 10% fetal bovine serum (BioClear) or in suspension in Sf900IISFM serum-free medium (Invitrogen). To produce recombinant proteins, insect cells seeded at a density of 0.5-1 ϫ 10 6 /ml were infected with the recombinant viruses at a multiplicity of 5. The cells were harvested 72 h after infection, washed with a solution of 0.15 M NaCl and 0.02 M phosphate, pH 7.4, homogenized in a 0.1 M NaCl, 0.1 M glycine, 10 M dithiothreitol, 0.1% Triton X-100, and 0.01 M Tris buffer, pH 7.8, and centrifuged. The pellets were further solubilized in 1% SDS, and aliquots of both fractions were analyzed by 10% SDS-PAGE under reducing conditions followed by Coomassie Blue staining or Western blotting with antibodies against the histidine (Amersham Biosciences) or GST (Pharmingen) tags.
Recombinant FIH with a C-terminal FLAGHis tag was purified with either an anti-FLAG M2 affinity gel (Sigma) or a chelating Sepharose charged with Ni 2ϩ (ProBond, Invitrogen). In FLAG affinity purification, the Triton X-100 extract of insect cells expressing FIH-FLAGHis was passed through the anti-FLAG M2 column several times and allowed to react with the affinity material for 1 h before washing with 0.15 M NaCl, 0.05 M Tris buffer, pH 7.4, and elution with the same buffer containing 100 g/ml FLAG peptide (Sigma). The elution buffer was kept in the column for 30 min before fractions of 1.5 ml were collected. In the purification with Ni 2ϩ -charged chelating Sepharose, the Triton X-100 extract was allowed to react with the Sepharose for 1 h before washing with a 0.3 M NaCl, 0.02 M imidazole, 0.02 M Tris buffer, pH 7.8, and elution with a gradient of 0.02-0.5 M imidazole. The fractions collected were analyzed by 10% SDS-PAGE under reducing conditions followed by Coomassie Blue staining. Fractions containing the purified FIHFLAGHis were pooled, and in the case of the Ni 2ϩ -charged chelating Sepharose-purified sample, the imidazole was removed by changing the buffer to 0.1 M NaCl, 0.1 M glycine, 10 M dithiothreitol, and 0.01 M Tris, pH 7.8, using an Ultrafree-15 centrifugal filter device with a Biomax-10 filter (Millipore). Next, the protein concentration was determined (RotiQuant, Carl Roth). Gel filtration to study the molecular weight of the recombinant FIH-FLAGHis was performed in a calibrated Superdex 200 column (Amersham Biosciences).
Assay of Enzyme Activity-FIH activity was assayed by a modified method based on the hydroxylation-coupled decarboxylation of 2-oxo [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]glutarate (25) . The reaction was performed in a final volume of 0.5 ml, which contained 10 -50 l of the Triton X-100 extracts of the insect cells expressing recombinant untagged or tagged FIH as a source of the enzyme, 100 nmol of the peptide DESGLPQLTSYDCEVNAPIQGSRN-LLQGEELLRAL (DES35, Innovagen, the residue corresponding to HIF-1␣ Asn 803 shown in bold) as a substrate, 5 nmol of FeSO 4 , 50 nmol of 2-oxo [1- 14 C]glutarate (50,000 dpm), 1 mol of ascorbate, 30 g of catalase (Sigma), 0.05 mol of dithiothreitol, 1 mg of bovine serum albumin (Sigma), and 25 mol of Tris-HCl buffer, adjusted to pH 7.8 at 25°C. The enzyme reaction was carried out at 37°C for 15 min unless otherwise indicated, the 14 CO 2 formed being trapped and counted as described (25) .
K m values for various peptide substrates (Innovagen), Fe 2ϩ , 2-oxoglutarate, ascorbate, and O 2 were determined by varying the concentration of a substrate or co-substrate, whereas the concentrations of the others were kept constant. The K m for O 2 was measured as described earlier for the HIF prolyl 4-hydroxylases (23) . The purified FIHFLAGHis was used as the source of the enzyme, and the low activity level generated even in the absence of added iron was subtracted from the final values when the K m for Fe 2ϩ was calculated. K i values were determined by adding the inhibitors at 4 -5 constant concentrations, whereas the concentration of 2-oxoglutarate was varied, using cell lysates from insect cells expressing FIH-FLAGHis as the source of enzyme. The catalytic center activity of the purified FIH-FLAGHis was measured under the reaction conditions described above, and the value was subsequently corrected for saturating concentrations of the peptide substrate DES35, Fe 2ϩ , 2-oxoglutarate, and oxygen.
RESULTS AND DISCUSSION
Recombinant Expression and Purification of FIH-
The recombinant FIH, His-FIH, FIH-FLAGHis, FIH-V5His, and GST-FIH polypeptides were expressed in insect cells, which were harvested 72 h after infection and homogenized in a buffer containing Triton X-100, and the soluble and insoluble fractions were analyzed by SDS-PAGE followed by Coomassie Blue staining and Western blotting. The FIH, FIH-FLAGHis, and FIH-V5His polypeptides were expressed at approximately equal levels, whereas the expression level of His-FIH was much lower (Fig. 1, A and B, lanes [3] [4] [5] [6] [7] [8] [9] [10] . About half of the recombinant His-FIH (Fig. 1B , lanes 5 and 6) and FIH-FLAGHis (Fig.  1, A and B, lanes 7 and 8) polypeptides could be solubilized with the Triton X-100 buffer, whereas the FIH (Fig. 1A, lanes 3 and  4) , FIH-V5His, and GST-FIH (Fig. 1, A and B, lanes 9 -12) polypeptides were found mostly in the insoluble fraction. Western blot analysis indicated that FIH-V5His was sensitive to degradation (Fig. 1B, lanes 9 and 10) , while FIH-FLAGHis and GST-FIH also showed some degradation, especially in the Triton X-100 buffer insoluble fraction ( Fig. 1 A and B, lanes 7, 8, 11, and 12) . FIH-FLAGHis was selected for purification, and an essentially homogenous protein was obtained by a single-step procedure using either anti-FLAG affinity (Fig. 2, lane 2) or chelating Sepharose (Fig. 2, lane 3) chromatography. Gel filtration experiments in a calibrated column indicated that FIHFLAGHis is a homodimer (details not shown), this result being in agreement with the structure of the crystallized enzyme (20 -22) .
Optimization of an Activity Assay and Measurement of Activities of Recombinant FIH Polypeptides-An assay based on the hydroxylation of a synthetic peptide substrate and measurement of the radioactivity of the 14 arate (25) was adopted and optimized here to measure the enzyme activity of FIH. The standard substrate used in these measurements was a synthetic 35-amino-acid peptide corresponding to residues 788 -822 in the C-terminal transactivation domain of HIF-1␣ and containing the Asn 803 hydroxylation site, the optimized assay conditions being those given under "Materials and Methods." The assay was found to be linear with increasing amounts of the Triton-X-100 extracts from insect cells expressing various FIH polypeptide forms (details not shown) or the purified recombinant FIH-FLAGHis polypeptide tested up to 800 nM concentration (Fig. 3A) . The assay was also linear with time for at least 20 min (Fig. 3B) , and the reaction gave characteristic Michaelis-Menten kinetics when the concentration of the 35-amino-acid peptide substrate (Fig.  4A) or any of the cosubstrates (as shown for 2-oxoglutarate in Fig. 4B ) was varied.
High levels of FIH activity were found in the Triton X-100-soluble fractions of insect cells expressing any of the recombinant FIH polypeptides except GST-FIH (Table I ). The differences in the activity values between the cell extracts do not reflect differences in the specific activities of the various FIH forms but rather differences in the amounts of the recombinant polypeptides present in the soluble fractions (Fig. 1) . The catalytic center activity of the purified FIH-FLAGHis (Fig. 2) was calculated from the activity values obtained by correcting them for saturating concentrations of the peptide substrate, Fe 2ϩ , 2-oxoglutarate, and oxygen. The catalytic center activities obtained for the enzyme purified by two alternative procedures were 85-135 and 70 -120 mol/mol/min, respectively (Table II) , the highest values probably being closest to the true activity, as the enzyme tended to become partially inactivated during purification (details not shown). These values are more than 1 order of magnitude higher than those reported for recombinant FIH produced in Escherichia coli (18) . This difference may be in part due to differences in the assay conditions used but may also be due to higher catalytic center activity in the recombinant enzyme expressed in insect cells than in that expressed in E. coli. It may be noted that for the three human HIF prolyl 4-hydroxylases, expression in insect cells gave markedly higher enzyme activity levels than expression in E. coli (23) . The catalytic center activity determined here is only about onethird of the highest value reported (26) for a purified recombinant human type I collagen prolyl 4-hydroxylase expressed in insect cells (Table II) but is slightly higher than the figures of 60 -100 mol/mol/min reported for a purified recombinant human lysyl hydroxylase isoenzyme 1 expressed in insect cells and its nonrecombinant counterpart (see Ref. 27 ).
Many 2-oxoglutarate dioxygenases have been shown to catalyze uncoupled decarboxylation of 2-oxoglutarate in the absence of the peptide substrate (12, 13) . The purified FIHFLAGHis was also found to catalyze this uncoupled decarboxylation, its rate being about 1% of the rate of the hydroxylation reaction observed in the presence of a saturating concentration of the 35-amino-acid peptide substrate (details not shown). This rate is slightly higher than the uncoupled reaction rate of 0.5% determined for a recombinant human type I collagen prolyl 4-hydroxylase relative to the rate observed in the presence of a saturating concentration of its substrate, (Pro-Pro-Gly) 10 (28) . (Table III) . The activity values obtained with peptide substrates lacking an increasing number of residues from the C terminus were markedly reduced, the activity decreasing to 26% with a peptide lacking just 4 residues, 819 -822, and to 9% with a peptide lacking residues 807-822 (Table III) . The peptide lacking residues 815-822 gave consistently higher activity values than the longer peptide lacking only 4 residues (Table III) , although no explanation is currently available for this finding. Omission of the N-terminal residues 788 -794 from a peptide already lacking the C-terminal residues 814 -822 resulted in a 19-residue peptide that gave an activity value of only about 10% of that obtained with a 27-residue peptide-(788 -814) containing one additional res- idue in its C terminus, and about 25% of that with a 23-residue peptide-(788 -810) lacking 3 residues from the C terminus relative to the N-terminally shortened peptide (Table III) . We also studied whether a 52-residue peptide (21) would be a better substrate than the 35-residue peptide, but we found that the K m values of these two peptides were identical, the activity values obtained with the two peptides being also very similar (Table III) .
The crystal structure of FIH with the C-terminal transactivation domain of HIF-1␣ has revealed the presence of two interaction sites, one (site 1) involving the HIF-1␣ residues 795-806 around the hydroxylation site itself and a second (site 2) involving the more C-terminal residues 813-822, suggested as representing a weaker binding site (21) . The present data indicate, however, that even site 2 is highly important, as the omission of only 4 residues from the C-terminal end of the 35-residue peptide led to a marked decrease in the activity observed (Table III) . Interestingly, residues located on the Nterminal side of those interacting at site 1 were also found to be important, as the omission of 7 residues, just preceding those interacting at site 1, likewise had a marked effect.
The three human HIF prolyl 4-hydroxylase isoenzymes (23) and the collagen prolyl 4-hydroxylases (12-14, 29) also require long peptide substrates. In the case of the HIF prolyl 4-hydroxylases, the minimum requirement is a peptide of more than 8 residues, whereas optimal interaction appears to require about 20 residues (23). The collagen prolyl 4-hydroxylases act even on tripeptides, although with very high K m values, long peptides being far better substrates (12) (13) (14) 29) . The present data and those reported previously (21) indicate that FIH requires particularly long peptide substrates (Table  III) .
Peptides Related to HIF-2␣ Are Far Less Efficient Substrates for FIH than Those Related To HIF-1␣-
The activities obtained with 35-and 19-residue peptides having a HIF-2␣ sequence were very low, only 7 and 1%, respectively, of that obtained with the 35-residue HIF-1␣ peptide, the activity obtained with the 19-residue HIF-2␣ peptide being one-quarter of that obtained with the corresponding 19-residue HIF-1␣ peptide (Table III). These findings suggest that FIH may act less effectively on HIF-2␣ than on HIF-1␣. In such a case, p300 might form a complex more readily with the former than the latter, and thus specific FIH inhibitors might show a stronger effect on genes regulated by HIF-1␣ than on those regulated by HIF-2␣. However, due to the complexity of the HIF system, detailed studies would be needed to investigate this possibility. (Table IV) . The K m of FIH for 2-oxoglutarate, 25 M, was distinctly lower than those of the HIF prolyl 4-hydroxylases, being very similar to that of the type I collagen prolyl 4-hydroxylase (Table IV) , whereas the K m for ascorbate, 260 M, was slightly higher than those of the HIF prolyl 4-hy- a Values are given in dpm/25 l and dpm/100 g of extractable cell protein from a typical expression experiment and in percent of the value obtained for FIH with no modifications. Essentially identical data were obtained in four independent experiments. Differences in the activity values do not represent differences in the specific activities of the recombinant polypeptides, as they differ in the amounts contained in the extraction buffer (Fig. 1) . droxylases, being again close to the value for the type I collagen prolyl 4-hydroxylase (Table IV) . Interestingly, the K m for O 2 , 90 M, was distinctly lower than those of the HIF prolyl 4-hydroxylases but definitely higher than that of the type I collagen prolyl 4-hydroxylase (Table IV) .
FIH (20 -22) and the collagen prolyl 4-hydroxylases (12-16) differ from all the other 2-oxoglutarate dioxygenases characterized so far in that the basic residue that binds the C-5 carboxyl group of 2-oxoglutarate in these enzymes is a lysine, whereas this residue in the HIF prolyl 4-hydroxylases (9 -11) and the other 2-oxoglutarate dioxygenases (14) is an arginine. Interestingly, the K m values of FIH and the collagen prolyl 4-hydroxylases for 2-oxoglutarate were very similar (Table IV) (see also Refs. 12-15), whereas the K m values of the HIF prolyl 4-hydroxylases were distinctly higher, although not as high as the values of 100 -140 M for the three human lysyl hydroxylase isoenzymes, in which the 2-oxoglutarate-binding residue is likewise an arginine (27) . Nevertheless, no data are currently available to indicate whether the differences in the K m values are indeed due to the differences in the 2-oxoglutarate-binding residue or to some other properties of the catalytic sites.
The K m of FIH for O 2 indicates that a minor decrease in O 2 concentration from that present in the air is likely to influence primarily the activities of the HIF prolyl 4-hydroxylases, the K m values of which are slightly above the concentration of dissolved O 2 in the air (23) . This will lead to increased HIF levels and activation of HIF-regulated genes. A larger decrease in O 2 concentration is needed for a significant decrease in the activity of FIH, which allows binding of p300 to HIF-␣ and thus leads to maximal transcriptional activity. These conclusions may only apply to cultured cells, however, as the O 2 concentrations of mammalian tissues under normoxic conditions (30) are so low that the activities of both the HIF prolyl 4-hydroxylases and FIH may be limited under normoxic conditions in vivo. As our experiments were performed with purified FIH, our data do not support the suggestion by others that the catalytic site of FIH may not act as a direct O 2 sensor, the O 2 sensing possibly requiring a complex formation with von Hippel Lindau and HIF-1␣ (22) .
FIH Has Unique K i Values for Several 2-Oxoglutarate Analog
Inhibitors-Distinct differences were found between FIH, the HIF prolyl 4-hydroxylases, and the type I collagen prolyl 4-hydroxylase in their inhibition by several 2-oxoglutarate analogs. The well characterized efficient competitive inhibitors of collagen prolyl 4-hydroxylases, pyridine-2,4-dicarboxylate and pyridine-2,5-dicarboxylate, were also found to inhibit FIH, but the K i values were increased about 15-and 60-fold, respectively, relative to those of the type I collagen prolyl 4-hydroxylase (Table V) . The K i of FIH for pyridine-2,4-dicarboxylate was slightly lower than that of HIF prolyl 4-hydroxylase 1 but about four times those of HIF prolyl hydroxylases 2 and 3 (Table V) . A striking difference between FIH and the HIF prolyl 4-hydroxylases was found in their inhibition by pyridine-2,5-dicarboxylate, as the latter enzymes are inhibited very inefficiently by this compound. Interestingly, the two most potent inhibitors of the HIF prolyl 4-hydroxylases among the compounds tested, 3-hydroxypyridine-2-carbonyl-glycine and N-((3-hydroxy-6-chloroquinolin-2-yl)carbonyl)glycine, were the least efficient inhibitors of FIH (Table V) . On the other hand, oxalylglycine and 3,4-dihydroxybenzoate were distinctly more potent inhibitors of FIH than of the HIF prolyl 4-hydroxylases, the K i values of FIH for these compounds, 2 and 10 M, respectively, being very close to those of the type I collagen prolyl 4-hydroxylase ( Table V) .
Compounds that increase the levels of HIF or enhance its transcriptional activity are believed to have a beneficial effect in the treatment of diseases characterized by acute or chronic ischemia, such as myocardial infarction, stroke, peripheral vascular disease, and diabetes (9 -11) . The most effective smallmolecule inhibitors identified so far for the collagen prolyl 4-hydroxylases (12) (13) (14) and the HIF prolyl 4 hydroxylases (23) are all 2-oxoglutarate analogs. Two such compounds, oxalylglycine and oxalylalanine, have been reported previously to inhibit FIH as well, the IC 50 for the former being 25 M (18, 21), i.e. more than 1 order of magnitude higher than the K i of 2 M determined here (Table V) . The compounds studied in the present work were all selected from those known to be effective inhibitors of the collagen prolyl 4-hydroxylases. It is significant, therefore, that two of them were also as good or almost as good inhibitors of FIH. All three classes of hydroxylase studied here had distinct inhibition properties, however. Our data indicate that there must be distinct differences in the structures of the 2-oxoglutrate-binding sites between the three classes of hydroxylase studied here, and it should thus be possible to develop potent small-molecule inhibitors of FIH that show a high specificity. As indicated above, one distinct property of FIH and the collagen prolyl 4-hydroxylases as compared with all the other 2-oxoglutarate dioxygenases characterized so far is that their residue binding the C-5 carboxyl group of 2-oxoglutarate is a lysine (12-16, 20 -22) . Another specific property of FIH is that the 2-oxoglutaratebinding lysine is located in the fourth ␤ strand of the jellyroll core that is typical of the 2-oxoglutarate dioxygenases (20 -22) , whereas the lysine/arginine present in both classes of prolyl 4-hydroxylase and many other 2-oxoglutarate dioxygenases is located in the eighth ␤ strand (9 -16). Nevertheless, it seems very likely that the positions of other residues located close to the 2-oxoglutarate-binding site also influence the binding properties of various inhibitors.
